Comparative study for glycemic control and adherence when adding DPP-4 inhibitor alogliptin to patients with type 2 diabetes who had been treated with three times administration of alpha-glucosidase inhibitors but still in poor glycemic control by maintaining, reducing, or stopping the administration of alpha-glucosidase inhibitors.
Not Applicable
Recruiting
- Conditions
- Type 2 Diabetes
- Registration Number
- JPRN-UMIN000004259
- Lead Sponsor
- Graduate School of Medicine, Yokohama City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who are receiving insulin therapy. 2.Patients who are taking anti-diabetic medicines other than alpha-GI 3.Patients who have a severe hepatic dysfunction. 4.Patients who have a severe renal dysfunction 5.Patients whose doctor in charge judges as inappropriate for the inclusion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c, glycoalbumin
- Secondary Outcome Measures
Name Time Method Body weight, adherence